Смекни!
smekni.com

Ступенчатая терапия: новый подход к применению антибактериальных препаратов (стр. 3 из 3)

Ramirez J., Ahkee S. Cost-savings associated to early switch from intravenous antimicrobials to oral clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia [abstract 12.06]. In: Abstracts of the 3rd ICMAS, Lisbon, Porugal, 1996, 83.

Российский фармацевтический бюллетень 1997, 40.

Eisen S., Miller D., Woodward R. et al: The effect of prescribed daily dose frequency on patient medication compliance. Arch. Intern. Med., 1990, 150, 1881-1884.

Cramer J., Mattson R., Prevey M. et al. How often medication taken as prescribed? A novel assessment technique. JAMA, 1985, 261, 3273-3277.

Quintiliani R., Cooper B., Briceland L. et al. Economic impact of streamlining antibiotic administration. Am. J. Med., 1987, 82 (Suppl.4A), 391-394.

Nathwani D. Cost-effectiveness considerations for combination therapies. In: Antibiotic combination therapy - the role of ciprofloxacin. Cambridge Medical Publications, 1997, 19.

Hamilton-Miller J. Switch therapy: the theory and practice of early change from parenteral to non-parenteral antibiotic administration. Clin. Microbiolog. Infection, 1996, 2, 12-19.

Jewesson P. Economic impact of intravenous-to-oral antibacterial stepdown therapy. Clin. Drug Invest., 1996, 11 (Suppl 2), 1-9.

Vogel F. Sequential therapy in the hospital management of lower respiratory infections. Am. J. Med., 1995, 99 (6B), 14S-19S.

Miller A., Hancock F. Sequential therapy for significant infection: a comparison of the efficacy, safety profile and cost of intravenous cefuroxime followed by oral cefuroxime axetil versus cefotaxime. In: Abstracts of the 7th ECCMID, Vienna, Austria, 1995, 128.

Regnier B. and Groupe d'Etude. Etude comparative du cefixime en relais oral de la ceftriaxone intraveneuse versus ceftriaxone seule dans le traitment des infections urinaires hautes severes. Presse Med., 1989, 18, 1617-1621.

Brambilla C., Kastanakis S., Knight S. et al. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections. Eur. J. Clin. Microbiol. Infect. Dis., 1992, 11, 118-124.